Requip is the first drug approved for restless legs syndrome

Requip is the first drug approved for restless legs syndrome.

About 10% of Americans get these overpowering urges to move their legs...especially when at rest.

Ropinirole (Requip) is a dopamine agonist...similar to pramipexole and pergolide. They're thought to help by boosting dopamine, a neurotransmitter responsible for controlling movement.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote